PEA for Burning Mouth Syndrome: The 600 mg Trial and What Came After
A preliminary randomized double-blind trial tested ultramicronized PEA at 600 mg twice daily for burning mouth syndrome. What it found, and how it compares.
PEA for Exercise Recovery and Muscle Soreness: What Three Trials Actually Found
Three trials tested PEA for exercise recovery and muscle soreness. One found a biomarker signal, one was clearly null, one was more complicated.
PEA for Autism Spectrum Disorder: What the Clinical Trial Evidence Actually Shows
What the 2018 trial of PEA in autism spectrum disorder actually tested, what the results showed, and what it does not establish for families.
PEA vs. Boswellia (Frankincense Extract) for Joint Inflammation: An Evidence-Based Comparison
PEA vs boswellia for joint inflammation: what the evidence supports for each, how the two compare fairly, and why some products combine them.
PEA Tolerance and Long-Term Use: Does It Lose Effectiveness Over Months or Years?
Does PEA stop working over time? What tolerance and tachyphylaxis mean, and why the research points the opposite direction for long-term use.
What Is Palmitoylethanolamide (PEA)? A Plain-English Introduction
PEA is a naturally occurring fatty acid your body already makes to calm pain and inflammation. Here’s what it is, how it works, and what the science says.
Palmitoylethanolamide vs Low-Dose Naltrexone: Two Non-Opioid Options Compared
PEA and LDN take different paths to address pain and neuroinflammation. Here’s an honest look at how their mechanisms, evidence, and tradeoffs compare.
Palmitoylethanolamide Side Effects and Safety: What Clinical and Post-Market Data Show
A review of clinical trial and systematic review data on palmitoylethanolamide (PEA) side effects, tolerability, and who should exercise caution.
PEA for Osteoarthritis: Joint Pain Support Without the Long-Term Risks of NSAIDs
How palmitoylethanolamide (PEA) may support knee osteoarthritis pain without NSAID risks—mechanism, clinical evidence, and honest caveats.
Palmitoylethanolamide, Mast Cells, and Neuroinflammation: The Cellular Science Behind the Signal
Explore how PEA stabilizes mast cells and modulates neuroinflammatory signaling through PPAR-α activation and the ALIA mechanism. Informational, not medical adv
Palmitoylethanolamide (PEA) for Endometriosis Pain: A Review of Emerging Clinical Evidence
Can PEA reduce pelvic and menstrual pain in endometriosis? We review clinical trials on palmitoylethanolamide endometriosis pain, mechanisms, and evidence limit
Palmitoylethanolamide (PEA) Dosage: How Much to Take, When, and Safety Notes (2026)
PEA dosage explained: the ranges used for chronic pain, when to take it, how micronized and ultramicronized forms differ, and the safety notes.